{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:18:50Z","timestamp":1790767130568,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["C38317\/A24043"],"award-info":[{"award-number":["C38317\/A24043"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["C8225\/A21133"],"award-info":[{"award-number":["C8225\/A21133"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20,014"],"award-info":[{"award-number":["IS-BRC-1215-20,014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20,007"],"award-info":[{"award-number":["IS-BRC-1215-20,007"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.breast.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T12:59:05Z","timestamp":1641301145000},"page":"145-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study"],"prefix":"10.1016","volume":"61","author":[{"given":"Anthony J.","family":"Maxwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-4409","authenticated-orcid":false,"given":"Karen","family":"Clements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2183-4763","authenticated-orcid":false,"given":"Joanne","family":"Dulson-Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-3035","authenticated-orcid":false,"given":"Olive","family":"Kearins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cliona","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Litherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0059-2275","authenticated-orcid":false,"given":"Senthurun","family":"Mylvaganam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3345-3965","authenticated-orcid":false,"given":"Elena","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8285-4111","authenticated-orcid":false,"given":"Elinor","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-0768","authenticated-orcid":false,"given":"Nisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Stobart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7141-281X","authenticated-orcid":false,"given":"Matthew G.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9855","key":"10.1016\/j.breast.2022.01.001_bib1","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2022.01.001_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.breast.2016.10.011","article-title":"Overdiagnosis in breast imaging","volume":"31","author":"Evans","year":"2017","journal-title":"Breast"},{"issue":"16","key":"10.1016\/j.breast.2022.01.001_bib3","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2022.01.001_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.breast.2022.01.001_bib5","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.breast.2022.01.001_bib6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jjco\/hyx059","article-title":"Current approach and future perspective for ductal carcinoma in situ of the breast","volume":"47","author":"Kanbayashi","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.breast.2022.01.001_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.breast.2022.01.001_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1470-2045(15)00446-5","article-title":"Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study","volume":"17","author":"Duffy","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2022.01.001_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1245\/s10434-019-07844-4","article-title":"Preoperative delays in the treatment of DCIS and the associated incidence of invasive breast cancer","volume":"27","author":"Ward","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2022.01.001_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1054\/bjoc.2001.1877","article-title":"Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings","volume":"85","author":"Thomson","year":"2001","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.breast.2022.01.001_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1148\/radiol.2017170673","article-title":"Detection rates of ductal carcinoma in situ with biennial digital mammography screening: radiologic findings support pathologic model of tumor progression","volume":"286","author":"Weigel","year":"2017","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.breast.2022.01.001_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejso.2017.12.007","article-title":"Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ","volume":"44","author":"Maxwell","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2022.01.001_bib13","unstructured":"NHS Breast Screening Programme AgeX Trial. http:\/\/www.agex.uk [Accessed 15 June 2021]."},{"key":"10.1016\/j.breast.2022.01.001_bib14","series-title":"England","first-page":"20","author":"Breast Screening Programme","year":"2019"},{"key":"10.1016\/j.breast.2022.01.001_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project","volume":"101","author":"Thompson","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2022.01.001_bib16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41416-020-01152-5","article-title":"Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project","volume":"124","author":"Shaaban","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2022.01.001_bib17","doi-asserted-by":"crossref","first-page":"m1570","DOI":"10.1136\/bmj.m1570","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.breast.2022.01.001_bib18","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.3747\/co.21.1604","article-title":"Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis","volume":"21","author":"Kong","year":"2014","journal-title":"Curr Oncol"},{"issue":"12","key":"10.1016\/j.breast.2022.01.001_bib19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrclinonc.2009.166","article-title":"Histological and molecular types of breast cancer: is there a unifying taxonomy?","volume":"6","author":"Weigelt","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.breast.2022.01.001_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0960-9776(03)00152-8","article-title":"The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry","volume":"12","author":"Claus","year":"2003","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.breast.2022.01.001_bib22","first-page":"135","article-title":"Ductal carcinoma in situ and progression to invasive cancer: a review of the evidence","volume":"3","author":"Heller","year":"2021","journal-title":"J\u00a0Breast Imaging"},{"issue":"9","key":"10.1016\/j.breast.2022.01.001_bib23","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","volume":"111","author":"Ryser","year":"2019","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.breast.2022.01.001_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/ajcp\/aqaa077","article-title":"Interobserver variability in ductal carcinoma in situ of the breast","volume":"154","author":"van Bockstal","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.breast.2022.01.001_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejca.2017.04.013","article-title":"The diagnostic challenge of low-grade ductal carcinoma in situ","volume":"80","author":"Onega","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2022.01.001_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cjp2.201","article-title":"Variability in grading of ductal carcinoma in situ among an international group of pathologists","volume":"7","author":"van Seijen","year":"2021","journal-title":"J\u00a0Pathol Clin Res"},{"issue":"1","key":"10.1016\/j.breast.2022.01.001_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.breast.2022.01.001_bib28","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","article-title":"Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials","volume":"24","author":"Grimm","year":"2017","journal-title":"Ann Surg Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:45:02Z","timestamp":1760777102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977622000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":27,"alternative-id":["S0960977622000017"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2022.01.001","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}